Sonobone
Our Story
Sonobone is used for drug testing. It reduces the dependency on lab animals for the purpose of testing.
On a winter morning in Gothenburg, in January 2016, CELLINK disrupted the biomaterials industry by
officially launching the world’s first universal bioink. Our goal was to make high-quality bioinks readily
available for researchers. We soon realized that while our bioink had massive potential to change how
research was conducted, our customers lacked the tools to truly unlock the advantages of this material.
Unfortunately, commercial 3D bioprinters weren’t as readily available. Immediately, we set out to change that.
By 2017, we were no longer just a bioink company but rather a full-scale 3D bioprinting company, actively working towards the democratization of the field by providing cutting edge, yet cost-effective
3D bioprinter systems. Allowing our customers to make breakthroughs that define the future of health.
Today we are industry leaders in the 3D bioprinting space. Working closer than ever with our customers to develop the systems, materials and tools needed to continue on this journey to create the future of health.
Our Team
Prajwal Agarwal
Co-founder, CEO
Sonobone
Prajwal Agrawal develops innovative addtive manufacturing technologies for applications ranging from food to muscle printing
Prof. Daniel Ahmed
Co-founder, Advisor Sonobone
Prof. Daniel Ahmed is the Assistant Professor of Acoustic Robotics for Life Sciences and Healthcare at ETH Zurich
Sonobone
+ 41 23452 24550
Rämistrasse 101,
8092 Zürich,
Switzerland
© 2024 Sonobone. All rights reserved.
Terms
Privacy
Cookies